Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 6 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 5 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Novavax (NASDAQ:NVAX) PT Raised to $18.00
ETF DAILY NEWS· 4 days agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price increased by Bank of America from $12.00 to $18.00 in a research report issued to clients and investors on Friday ...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 2 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress of COVID-19 vaccine trials in the country, the source said.
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
InvestorPlace· 1 day agoIt was not long ago that Novavax (NASDAQ:NVAX) was among the stocks with high short interest. In the...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...